Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Clinical Imbalances

Hormonal

Structural Integrity and Musculoskeletal

Modifiable Lifestyle Factors

Diet

Text Availability

Abstract

397

Full text

330

Free full text

125

Publication Types

Journal Article

408

Randomized Controlled Trial

241

Research Support, Non-U.S. Gov't

164

Clinical Trial

120

Review

Multicenter Study

Comparative Study

Research Support, U.S. Gov't, P.H.S.

Systematic Review

Research Support, N.I.H., Extramural

Controlled Clinical Trial

Meta-Analysis

Case Reports

Observational Study

Retracted Publication

Clinical Trial, Phase III

Research Support, U.S. Gov't, Non-P.H.S.

Comment

Consensus Development Conference

Network Meta-Analysis

Clinical Trial Protocol

Clinical Trial, Phase II

Letter

Evaluation Study

Scoping Review

News

Patient Education Handout

Editorial

Publication Year

From

Quick links

Individual year

2025

2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2006

2005

2004

2003

2002

2001

2000

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Alendronate""[mesh_terms]

411 Results

Searching titles within these results

Novel formulations of oral bisphosphonates in the treatment of osteoporosis.

Mickael Hiligsmann, Olivier Bruyère, Régis Pierre Radermecker, Nicola Veronese, John A Kanis, Nicholas Fuggle, Philippe Halbout, Friederike Thomasius, Nasser Al-Daghri, Maarten de Wit, Olivier Bock, Jaime Branco, Enrique Casado, Etienne Cavalier, Bernard Cortet, Andrea Giusti, Nicholas C Harvey, Jean-Marc Kaufman, Andreas Kurth, Stefania Maggi, Radmila Matijevic, Salvatore Minisola, Santiago Palacios, Sansin Tuzun, Jean-Yves Reginster, René Rizzoli, Cyrus Cooper

Aging clinical and experimental research 2022;34(11):2625-2634

Free Full Text

Abstract

Effects of alendronate plus alfacalcidol in osteoporosis patients with a high risk of fracture: the Japanese Osteoporosis Intervention Trial (JOINT) - 02.

Hajime Orimo, Toshitaka Nakamura, Masao Fukunaga, Hiroaki Ohta, Takayuki Hosoi, Yukari Uemura, Tatsuhiko Kuroda, Nobuaki Miyakawa, Yasuo Ohashi, Masataka Shiraki

Current medical research and opinion 2011;27(6):1273-84

Full Text

Abstract

Considerations of osteoporosis prevention in an aging society.

D Hamerman

Maturitas 2001;37(2):69-73

Full Text

Abstract

Important aspects concerning alendronate-related osteonecrosis of the jaws: a literature review.

Julia E Iglesias, Fernanda G Salum, Maria A Figueiredo, Karen Cherubini

Gerodontology 2017;32(3):169-78

Full Text

Abstract

The treatment of severe postmenopausal osteoporosis : a review of current and emerging therapeutic options.

Jean-Yves Reginster, Nathalie Sarlet

Treatments in endocrinology 2016;5(1):15-23

Free Full Text

Abstract

Is there a role for bisphosphonates in vascular calcification in chronic kidney disease?

S Hildebrand, J Cunningham

Bone 2021;142():115751

Full Text

Abstract

Osteoporosis in men.

Jant M Campion, Michael J Maricic

American family physician 2003;67(7):1521-6

Free Full Text

Abstract

Vitamin D intoxication and therapy with alendronate (case report and review of literature).

Zerrin Orbak, Hakan Doneray, Filiz Keskin, Ahmet Turgut, Handan Alp, Cahit Karakelleoglu

European journal of pediatrics 2007;165(8):583-4

Full Text

Design of a pragmatic approach to evaluate the effectiveness of concurrent treatment for the prevention of osteoporotic fractures: rationale, aims and organization of a Japanese Osteoporosis Intervention Trial (JOINT) initiated by the Research Group of Adequate Treatment of Osteoporosis (A-TOP).

Masataka Shiraki, Tatsuhiko Kuroda, Nobuaki Miyakawa, Naohito Fujinawa, Kazumasa Tanzawa, Akiko Ishizuka, Shiro Tanaka, Yukari Tanaka, Takayuki Hosoi, Eiji Itoi, Shigeto Morimoto, Akira Itabashi, Toshitsugu Sugimoto, Toshihiko Yamashita, Itsuo Gorai, Satoshi Mori, Hideaki Kishimoto, Hideki Mizunuma, Naoto Endo, Yoshiki Nishizawa, Kunio Takaoka, Yasuo Ohashi, Hiroaki Ohta, Masao Fukunaga, Toshitaka Nakamura, Hajime Orimo

Journal of bone and mineral metabolism 2011;29(1):37-43

Full Text

Abstract

Efficacy and safety of weekly alendronate plus vitamin D₃ 5600 IU versus weekly alendronate alone in Korean osteoporotic women: 16-week randomized trial.

Kwang Joon Kim, Yong-Ki Min, Jung-Min Koh, Yoon-Sok Chung, Kyoung Min Kim, Dong-Won Byun, In Joo Kim, Mikyung Kim, Sung-Soo Kim, Kyung Wan Min, Ki Ok Han, Hyoung Moo Park, Chan Soo Shin, Sung Hee Choi, Jong Suk Park, Dong Jin Chung, Ji Oh Mok, Hong Sun Baek, Seong-Hwan Moon, Yong Soo Kim, Sung-Kil Lim

Yonsei medical journal 2015;55(3):715-24

Free Full Text

Abstract

Long-term administration of alendronate sodium caused an atypical femoral shaft fracture in a 36-year-old woman: a case report and literature review.

Haidong Zhang, Wenyu Duan, Maochang Qiang, Dongming Zhou

The Journal of international medical research 2024;52(10):3000605241286650

Free Full Text

Abstract

Current indications for prevention and therapy of steroid-iduced osteoporosis in men and women.

Ewa Sewerynek

Endokrynologia Polska 2011;62(1):38-44

Free Full Text

Abstract

Effects of two intermittent alendronate regimens in the prevention or treatment of postmenopausal osteoporosis.

M Rossini, D Gatti, S Girardello, V Braga, G James, S Adami

Bone 2000;27(1):119-22

Full Text

Abstract

The efficacy of alendronate for the treatment of thalassemia-associated osteoporosis: a randomized controlled trial.

Somdet Srichairatanakool, Thanawat Rattanathammethee, Ekarat Rattarittamrong, Adisak Tantiworawit, Chatree Chai-Adisaksopha, Pokpong Piriyakhuntorn, Mattabhorn Phimphilai, Waralee Teeyasoontranon, Sasinee Hantrakool, Lalita Norasetthada, Kanda Fanhchaksai, Pimlak Charoenkwan

Frontiers in endocrinology 2023;14():1178761

Free Full Text

Abstract

Alendronate prevents bone loss in Chinese women with osteoporosis.

J Woo, E M Lau, Y H Chan, J Griffith

Bone 2000;27(5):677-80

Full Text

Abstract

Results: 1 – 15 / 411

Filters

Expert Opinion

Clinical Imbalances

Modifiable Lifestyle Factors

Text Availability

Publication Types

Publication Year

Results for ""Alendronate""[mesh_terms]

Novel formulations of oral bisphosphonates in the treatment of osteoporosis.

Effects of alendronate plus alfacalcidol in osteoporosis patients with a high risk of fracture: the Japanese Osteoporosis Intervention Trial (JOINT) - 02.

Considerations of osteoporosis prevention in an aging society.

Important aspects concerning alendronate-related osteonecrosis of the jaws: a literature review.

The treatment of severe postmenopausal osteoporosis : a review of current and emerging therapeutic options.

Is there a role for bisphosphonates in vascular calcification in chronic kidney disease?

Osteoporosis in men.

Vitamin D intoxication and therapy with alendronate (case report and review of literature).

Design of a pragmatic approach to evaluate the effectiveness of concurrent treatment for the prevention of osteoporotic fractures: rationale, aims and organization of a Japanese Osteoporosis Intervention Trial (JOINT) initiated by the Research Group of Adequate Treatment of Osteoporosis (A-TOP).

Efficacy and safety of weekly alendronate plus vitamin D₃ 5600 IU versus weekly alendronate alone in Korean osteoporotic women: 16-week randomized trial.

Long-term administration of alendronate sodium caused an atypical femoral shaft fracture in a 36-year-old woman: a case report and literature review.

Current indications for prevention and therapy of steroid-iduced osteoporosis in men and women.

Effects of two intermittent alendronate regimens in the prevention or treatment of postmenopausal osteoporosis.

The efficacy of alendronate for the treatment of thalassemia-associated osteoporosis: a randomized controlled trial.

Alendronate prevents bone loss in Chinese women with osteoporosis.

Results for
""Alendronate""[mesh_terms]